Women`s Rights Center

 

           
Domestic Violence National Hot Line

 

      (010) 54 28 28

         0800 80 850

 

Make a Donation

Women’s Sexual and Reproductive Health and Rights 

   

 

 

 

 

 

 

 

 

 

 

 

 

Women’s Sexual and Reproductive Health and Rights are important issues for the world society. Everybody has the right to accessible, affordable and adequate health care. Millions of women every year seek to terminate their unwanted pregnancies. According to World Health Organization report there are 28 abortions for every 1,000 women of childbearing age globally. In 2008, the estimated annual number of deaths from unsafe abortion worldwide declined from 56,000 in 2003 to 47,000 in 2008. Complications from unsafe abortion accounted for an estimated 13% of all maternal deaths worldwide in both years. Regarding the index of reproductive health Armenia considerably yields to the European Union indexes. Suffice it to note that the rate of maternal and child death is several times higher than that of the developed countries.

In Armenia surgical abortion remains one of the widely used methods for terminating unwanted pregnancy. According to the Armenian National Statistical Service data for 2010 the induced abortion rate is 28 per 1,000 women. Enlargement of induced abortion services is one of the important steps in improving quality of women’s reproductive health care. Women's Rights Center was the first to introduce medical abortion as an alternative way of terminating unwanted pregnancies. Medical abortion is a type of non-surgical abortion in which pharmaceutical drugs are used to induce abortion. All activities of Women's Rights Center on safe abortion are realized with the permission and in cooperation with the Ministry of Health of RA.

 

Starting from 2007 Women's Rights Center has organized trainings with the obstetrician-gynecologists in Yerevan, Gyumri and Vanadzor on the 1st trimester (9-12 weeks) unwanted pregnancy termination, as well as raised awareness through publications on the issue and its dissemination among the above mentioned specialists. Medicines which are necessary for medical abortion - mifepristone and misoprostol - were registered in Armenia in 2007 and 2008 accordingly in cooperation with the Ethics Committee of Yerevan State Medical University after Mkhitar Heratsi (YSMU). It is about three decades that medical abortion with the usage of mifepristone and misoprostol has been proved to be safe, effective, and acceptable option for terminating unwanted pregnancy. In 2013 monitoring and evaluation research studies on 1st trimester medical abortion have been implemented in 5 hospitals in Yerevan, Gyumri and Vanadzor.  

From April 2014 Women's Rights Center has implemented all the necessary work for starting a new clinical research study on termination of pregnancy in 2nd trimester (13-22 weeks). It must be noted that according to the legislation of the Republic of Armenia second trimester abortion can be realized only by medical or social indications. Mifepriston and misoprostol have been reregistered for usage in the second trimester medical abortion clinical study and the corresponding package of the documents was also developed for the approval of the Ethics Committee of YSMU. After receiving positive conclusion from the Ethics Commitee the above mentioned clinical study has been launched and now it is implemented at the Republican Institute of Reproductive Health, Perinatology, Obstetrics and Gynecology in Yerevan (RIRHPOG). The aim of this research study is investigation on medical abortion with the use of mifepristone and misoprostol, results and success rate, its acceptability and feasibility for women in Armenia.

Within the framework of the project a new Clinical Guideline on organization and delivery of medical aid in medical abortion (1st and 2nd trimesters) was elaborated by the Working Group and published for its further dissemination among health providers. 

It’s important to note that from August 1st, 2014, according to the decree of the Ministry of Health of the Republic of Armenia, sale of the misoprostol (cytotec) without prescription is prohibited. The necessity for such decision was stipulated by the wrong regimen of the drugs usage by women at home.

 

 

News
Provision of Supportive Services for Combating Domestic Violence
Elaboration of Appropriate Legal Mechanisms
Awareness Raising and Educational Campaigns
Awareness Raising on Sexual and Reproductive Health and Rights
Archive

Home  |  Activities  |  About us  |  Publications  |  Gallery  |  Contacts
Developed by Smart Systems LLC
en
am